We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MRNO:NASDAQMurano Global Investments PLC Analysis

Data as of 2026-04-18 - not real-time

$0.44

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Murano Global Investments is trading well below its 20‑day, 50‑day and 200‑day simple moving averages, a classic bearish alignment that underscores the downtrend. The RSI hovering in the high‑30s signals oversold conditions, yet the momentum remains weak as volume has been consistently decreasing. Technical indicators show a marginally bullish MACD histogram, but the overall picture is dominated by a bearish price action, with the current price sitting near the identified support level and well under the resistance zone. Volatility is extreme, with a 30‑day swing exceeding 170% and a beta well above 1, indicating that price moves are highly amplified relative to the market.
Fundamentally, the company is under severe financial strain: debt-to‑equity exceeds 200, operating and profit margins are deeply negative, and free cash flow is in the red by over a billion dollars. While revenue growth is respectable, the balance sheet is eroded by massive leverage and cash burn, leaving little room for sustainable earnings. The stock trades at a fraction of book value and price‑to‑sales, reflecting the market’s pricing of this distress, but the absence of dividends and the high debt load raise serious concerns about long‑term viability.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 9/10

Key Factors

  • Price below all major moving averages
  • Decreasing volume trend
  • Extreme leverage and negative cash flow

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Continued debt overhang
  • Limited upside from revenue growth
  • High volatility and beta

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Structural balance‑sheet weakness
  • Uncertain restructuring prospects
  • Persistent market‑wide risk in real‑estate development

Key Metrics & Analysis

Financial Health

Revenue Growth23.90%
Profit Margin-163.61%
ROE-35.40%
ROA-1.80%
Debt/Equity209.24
P/B Ratio0.1
Op. Cash Flow$-137758736
Free Cash Flow$-1154351104
Industry P/E34.0

Technical Analysis

TrendBearish
RSI39.7
Support$0.40
Resistance$0.65
MA 20$0.50
MA 50$0.65
MA 200$2.86
MACDBullish
VolumeDecreasing
Fear & Greed Index90.21

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta1.46
Volatility173.29%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.